Athersys, Inc / New 10K 2022 Annual report | ATHXQ Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbott, Abeona, accrual, Acorda, advisor, Africa, Akebia, AnaptysBio, Ankura, Ardelyx, arm, Arnosti, ascribed, Astex, ASTX, ATMP, atrophy, attending, attrition, Australia, Australian, AVEO, BeCareLink, bedrock, belief, benchmarking, Bio, BioDirector, biopharma, Biotie, Birmingham, BITI, BJ, brought, bulk, calendar, Calithera, Cambridge, canceled, Cape, cast, categorized, CDG, Centre, CFO, cGMP, check, Chimerix, clawback, cliff, COBRA, Concert, concomitant, confidence, consecutive, Counsel, COVID, culpable, cutting, deal, decommissioning, dedicated, deductible, deficiency, delist, delisted, delisting, denoted, dental, departmental, departure, developmental, digital, disagree, disproportionate, disqualify, distributor, dividing, dozen, Eiger, entail, Epizyme, equitably, escalation, Eversana, EXEL, exit, exiting, expert, fact, Fellow, foregone, Forepont, forfeiture, formula, foster, fundamental, Geron, GIMV, GPN, half, Hansen, hardship, Harvard, headcount, hedge, Hedging, Hemanex, highest, Hub, hundred, ideal, inconsistent, Infinion, Infinity, insight, Invicta, iPSP, Jaguar, Jane, JD, Joseph, Kalin, Karolinska, Kasey, Katherine, Kenneth, KJE, leader, Lehman, length, Lieutenant, linking, lt, Lundbeck, Maastricht, Maia, man, managerial, Marathon, Med, Mellon, mindful, mission, Missouri, modernize, modestly, Monash, month, morale, muscular, MutliStem, narrative, Navy, Newcastle, Nolan, noncompliance, nonpayment, notionally, Nuffield, NY, NYSE, Oncology, Ondek, online, organizational, OTC, Oxford, par, path, paused, pausing, pediatric, Pembroke, perspective, Pharmacia, PhD, philosophy, PIP, Pitt, placement, pocket, postponed, predefined, premium, preset, Princeton, professor, Professorship, programmatic, Promega, promissory, prompt, Pty, ratification, realignment, reallocation, reclassified, recoup, recoupment, recruit, recruiting, refinancing, relinquish, repositioning, repurchase, restart, restructuring, Rhythm, Rigel, RIGL, Rosado, sample, scrutiny, Secretary, Sesen, SiteOne, size, SLS, South, specialty, speculate, Speculation, split, squeeze, statistician, statutorily, Stockholm, strongly, sublet, subletting, substantive, sudden, superseding, Sweden, Syndax, Synosia, Syracuse, tab, thereof, topline, Town, transformation, Traub, Tulane, twenty, Tyme, UCB, UGNE, unclear, undergraduate, undue, Unigene, unintended, unpaid, vehicle, venture, Verastem, Veru, vision, VWR, waive, Wasman, wind, xoma, York, Ziopharm

Removed: accountant, addressing, afforded, American, Amgen, Arizona, aspect, assembled, attached, Background, billion, Biochemistry, Biology, Bokkelen, BV, career, Certified, communicate, compound, comprise, concurrently, conferred, consent, continuance, CPA, creation, cryogenic, dated, Deepen, defer, deferring, Delaware, Diego, dispense, document, driven, Eisai, encompassed, executed, exempt, exhibit, extensively, finalize, formally, founding, Gamida, generation, Gil, globally, GMP, Goodrich, grow, inflationary, MIT, molecule, multinational, occupation, optimizing, originated, overseen, pipeline, Plureon, predominant, prevailing, protein, RAGE, recommendation, refine, refractory, restated, Roche, Rosati, runway, San, satisfaction, saving, Scotland, securely, shortfall, Silicon, solid, Sonsini, source, specificity, staging, Stanford, stepping, store, top, ulcerative, unaudited, unregistered, Valley, Van, Virginia, Wilson


Name of Subsidiary						Jurisdiction
ABT Holding Company (formerly Athersys, Inc.)						Delaware
Advanced Biotherapeutics, Inc.						Delaware
Athersys GK						Japan
Athersys Limited						United Kingdom
ReGenesys LLC						Delaware
ReGenesys BV						Belgium
ReGenesys EU NV						Belgium

Athersys, Inc / New (ATHXQ) 10-K2022 FY Annual report

Content analysis